You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
10 April 2026 - Chinese biopharmaceutical company DualityBio (HK:9606) announced on Thursday that the Biologics License Application (BLA) for the investigational antibody-drug conjugate (ADC) trastuzumab pamirtecan ('T-Pam', also known as D...
10 April 2026 - Oricell Therapeutics Holdings Limited, a clinical-stage biotechnology company developing next-generation cell therapies for oncology and immunology, announced on Thursday the cumulative closing of a pre-IPO financing round in excess o...
9 April 2026 - Technology company Tempus AI Inc (NASDAQ:TEM) on Thursday announced an expanded multi-year collaboration with biopharmaceutical company Gilead Sciences Inc (Nasdaq:GILD) to support the development of Gilead's oncology pipeline.The...
8 April 2026 - Solvonis Therapeutics plc (LSE: SVNS), a biopharmaceutical company developing small-molecule treatments for central nervous system disorders, announced on Wednesday that it has been granted a second US patent (No. 12,595,269) covering ...
8 April 2026 - Biopharmaceutical company GSK plc (LSE: GSK) (NYSE: GSK) revealed on Wednesday that it has received approval from China's National Medical Products Administration for Exdensur (depemokimab) as an add-on treatment for adults with c...
8 April 2026 - AI-powered, integrated digital health company MedPal AI plc (AIM: MPAL) (FRA: Z1N) declared on Wednesday that it has launched its MedPal Health Operating System, a vertically integrated digital health platform designed to deliver perso...